EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity

Domenico Tricò iD, Eleni Rebelos iD, Brenno Astiarraga, Simona Baldi, Tiziana Scozzaro, Luca Sacchetta, Martina Chiriacò, Andrea Mari, Ele Ferrannini, Elza Muscelli iD, Andrea Natali

The Journal of Clinical Endocrinology & Metabolism · 18.02.2025 · 110 (3) · e667-e674

DOI: 10.1210/clinem/dgae276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 18.04.2024. Verfasst von Domenico Tricò und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Fatty Acids, Nonesterified, Hypertriglyceridemia, Insulin Resistance. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Foundation for the Study of Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hypertriglyceridemia is a risk factor for developing type 2 diabetes (T2D) and might contribute to its pathogenesis either directly or through elevation of nonesterified fatty acids (NEFAs).

Objective

This study aimed at comparing the glucometabolic effects of acute hypertriglyceridemia alone or combined with NEFA elevation in subjects without diabetes.

Methods

Twenty-two healthy lean volunteers underwent 5-hour intravenous infusions of either saline or Intralipid, without (n = 12) or with heparin (I + H; n = 10) to activate the release of NEFAs. Oral glucose tolerance tests (OGTTs) were performed during the last 3 hours of infusion. Insulin sensitivity, insulin secretion rate (ISR), model-derived β-cell function, and insulin clearance were measured after 2 hours of lipid infusion and during the OGTTs.

Results

In fasting conditions, both lipid infusions increased plasma insulin and ISR and reduced insulin clearance without affecting plasma glucose and insulin sensitivity. These effects on insulin and ISR were more pronounced for I + H than Intralipid alone. During the OGTT, the lipid infusions markedly impaired glucose tolerance, increased plasma insulin and ISR, and decreased insulin sensitivity and clearance, without significant group differences. Intralipid alone inhibited glucose-stimulated insulin secretion (ie, β-cell glucose sensitivity) and increased β-cell potentiation, whereas I + H had neutral effects on these β-cell functions.

Conclusion

In healthy nonobese subjects, mild acute hypertriglyceridemia directly reduces glucose tolerance and insulin sensitivity and clearance, and has selective and opposite effects on β-cell function that are neutralized by NEFAs. These findings provide new insight into plausible biological signals that generate and sustain insulin resistance and chronic hyperinsulinemia in the development of T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsFatty Acids, NonesterifiedHypertriglyceridemiaInsulin ResistanceInsulinHumansMaleAdultGlucose Tolerance TestFemaleFat Emulsions, IntravenousBlood GlucoseInsulin SecretionSoybean OilPhospholipidsYoung AdultDiabetes Mellitus, Type 2Emulsions

Stichwörter der Autor:innen

hypertriglyceridemiainsulin clearanceinsulin secretioninsulin sensitivitynonesterified fatty acidsoral glucose tolerancetype 2 diabetes

Substanzen

Fatty Acids, NonesterifiedInsulinFat Emulsions, IntravenousBlood Glucosesoybean oil, phospholipid emulsionSoybean OilPhospholipidsEmulsions

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
  • Laboratory of Metabolism, Nutrition, and Atherosclerosis, University of Pisa, 56126 Pisa, Italy.
  • Hospital Universitari Joan XXIII de Tarragona, Institut d'Investigació Sanitària Pere Virgili (IISPV), 43005 Tarragona, Spain.
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
  • Institute of Neuroscience, National Research Council, 35127 Padua, Italy.
  • Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

ORCID-Profile: Domenico Tricò, Eleni Rebelos, Elza Muscelli

Förderung

  • European Foundation for the Study of Diabetes

Zitieren

APA

Tricò, D., Rebelos, E., Astiarraga, B., Baldi, S., Scozzaro, T., Sacchetta, L., Chiriacò, M., Mari, A., Ferrannini, E., Muscelli, E., & Natali, A. (2025). Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity. The Journal of Clinical Endocrinology & Metabolism, 110(3), e667-e674. https://doi.org/10.1210/clinem/dgae276

Vancouver

Tricò D, Rebelos E, Astiarraga B, Baldi S, Scozzaro T, Sacchetta L, et al. Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity. The Journal of Clinical Endocrinology & Metabolism. 2025;110(3):e667-e674. doi:10.1210/clinem/dgae276

BibTeX
@article{Tric2025,
  author = {Tricò, Domenico and Rebelos, Eleni and Astiarraga, Brenno and Baldi, Simona and Scozzaro, Tiziana and Sacchetta, Luca and Chiriacò, Martina and Mari, Andrea and Ferrannini, Ele and Muscelli, Elza and Natali, Andrea},
  title = {Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {3},
  pages = {e667--e674},
  doi = {10.1210/clinem/dgae276}
}
Kostenlos starten →